2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Biologics inch toward cholesterol-lowering market.

      Nature biotechnology
      Clinical Trials, Phase III as Topic, economics, Drug Approval, Drug Industry, Humans, Hypercholesterolemia, therapy, Lipoproteins, LDL, Proprotein Convertases, therapeutic use, Serine Endopeptidases, United States, United States Food and Drug Administration

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Comments

          Comment on this article